AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
19 Aug 2002 11:30 AM
RNS
Iressa Announcement
15 Aug 2002 07:00 AM
RNS
Purchase of Own Securities
14 Aug 2002 07:00 AM
RNS
Purchase of Own Securities
12 Aug 2002 07:00 AM
RNS
Purchase of Own Securities
09 Aug 2002 07:00 AM
RNS
Purchase of Own Securities
08 Aug 2002 07:00 AM
RNS
Purchase of Own Securities
07 Aug 2002 01:00 PM
RNS
Iressa
06 Aug 2002 02:00 PM
RNS
Update on Crestor
25 Jul 2002 11:00 AM
RNS
Interim Results - Part 2
25 Jul 2002 11:00 AM
RNS
Interim Results - Part 1
24 Jul 2002 09:00 AM
RNS
Notice of Results
05 Jul 2002 07:13 AM
RNS
Iressa In Japan
28 Jun 2002 07:00 AM
RNS
Purchase of Own Securities
27 Jun 2002 07:00 AM
RNS
Purchase of Own Securities
26 Jun 2002 07:00 AM
RNS
Purchase of Own Securities
25 Jun 2002 07:00 AM
RNS
Purchase of Own Securities
24 Jun 2002 07:00 AM
RNS
Purchase of Own Securities
21 Jun 2002 07:00 AM
RNS
Research Update
17 Jun 2002 07:00 AM
RNS
Purchase of Own Securities
14 Jun 2002 07:00 AM
RNS
Purchase of Own Securities
13 Jun 2002 04:00 PM
RNS
Holding(s) in Company
13 Jun 2002 07:00 AM
RNS
Purchase of Own Securities
10 Jun 2002 07:00 AM
RNS
Purchase of Own Securities
07 Jun 2002 07:00 AM
RNS
Purchase of Own Securities
05 Jun 2002 09:38 AM
RNS
Regulatory Approval
05 Jun 2002 07:00 AM
RNS
Purchase of Own Securities
30 May 2002 07:00 AM
RNS
Purchase of Own Securities
29 May 2002 07:00 AM
RNS
Purchase of Own Securities
28 May 2002 07:00 AM
RNS
Purchase of Own Securities
24 May 2002 01:00 PM
RNS
Retirement
24 May 2002 07:00 AM
RNS
Purchase of Own Securities
23 May 2002 07:00 AM
RNS
Purchase of Own Securities
21 May 2002 07:00 AM
RNS
Purchase of Own Securities
20 May 2002 09:00 AM
RNS
Iressa Study Results
17 May 2002 07:00 AM
RNS
Purchase of Own Securities
16 May 2002 08:00 AM
RNS
Crestor Co-Marketing
15 May 2002 07:00 AM
RNS
Purchase of Own Securities
14 May 2002 07:00 AM
RNS
Purchase of Own Securities
13 May 2002 07:00 AM
RNS
Purchase of Own Securities
10 May 2002 07:00 AM
RNS
Purchase of Own Securities
09 May 2002 07:00 AM
RNS
Purchase of Own Securities
08 May 2002 05:10 PM
RNS
Director Shareholding
07 May 2002 04:00 PM
RNS
Holding(s) in Company
07 May 2002 07:00 AM
RNS
Purchase of Own Securities
03 May 2002 07:00 AM
RNS
Purchase of Own Securities
02 May 2002 07:00 AM
RNS
Purchase of Own Securities
01 May 2002 07:00 AM
RNS
Purchase of Own Securities
29 Apr 2002 07:00 AM
RNS
Purchase of Own Securities
26 Apr 2002 04:00 PM
RNS
Director Shareholding
26 Apr 2002 07:23 AM
RNS
FDA Approval - Faslodex
AstraZeneca PLC, known as AZN on the London Stock Exchange (LSE), is an Anglo-Swedish multinational pharmaceutical and biotechnology company. Founded on April 6, 1999, AstraZeneca was formed through the merger of the Swedish Astra AB and the British Zeneca Group. The company's roots trace back to 1913, when Astra AB was established by a group of doctors and apothecaries in Södertälje, Sweden. Throughout the twentieth century, AstraZeneca grew into one of the largest pharmaceutical companies in the world. It has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). Today, AstraZeneca operates in over 100 countries and employs around 83,000 people. As a member of the LSEG, AZN continues to shape the global healthcare landscape. The company is committed to defeating diseases that impact people's health.
UK 100